bis(5-amidino-2-benzimidazolyl)methane and uk-356,202

bis(5-amidino-2-benzimidazolyl)methane has been researched along with uk-356,202 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barber, CG; Brown, DG; Butt, R; Collis, MG; Dickinson, RP; Fish, PV; Henry, BT; Horne, VA; Huggins, JP; King, E; McCleverty, D; McIntosh, F; O'Gara, M; Phillips, C; Webster, R1

Other Studies

1 other study(ies) available for bis(5-amidino-2-benzimidazolyl)methane and uk-356,202

ArticleYear
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines.
    Journal of medicinal chemistry, 2007, May-17, Volume: 50, Issue:10

    Topics: Acute Disease; Animals; Anti-Ulcer Agents; Binding Sites; Chronic Disease; Crystallography, X-Ray; Guanidines; Humans; In Vitro Techniques; Models, Molecular; Protein Binding; Quinolines; Skin; Skin Diseases; Structure-Activity Relationship; Sulfonamides; Swine; Ulcer; Urokinase-Type Plasminogen Activator; Wound Healing

2007